GSK narrows focus on elderly in trial to treat pneumonia from COVID-19

Subscribe
Get in touch

Before you go we'd just like to ask you a quick question!

Your vote has been counted in the results below.

If you could vote on Brexit now which option would you choose?
Remain Leave

GSK narrows focus on elderly in trial to treat pneumonia from COVID-19

GlaxoSmithKline will extend a trial testing an experimental rheumatoid arthritis drug on patients suffering from pneumonia related to COVID-19 to focus on the elderly as it seeks to firm up encouraging findings so far.

Reuters - February 25, 2021

View the full story here: https://www.reuters.com/article/health-coronavirus-gsk-otilimab-idUSL8N2KT6D6

Contact Us

franklin@cccovid19.org
Our contact form
Curator login

Quick Links

Privacy policy
Terms & Conditions
Cookie Policies

Keep up to date with Connecting Communities for COVID19

Name*

Email*

Region*

Enter your region from the drop-down menu so we can tailor the news to you.

Privacy Policy | Terms & Conditions | Cookie Policies

Select or add an image to the Image library

Show only large

Search image library using the following tags

Cookie Notice - News Finder - corona_virus

We use cookies to enhance your visit to our site.
Read our Privacy policy, Cookie Policies and Terms & Conditions to find out more.